Altogether the findings of Liu et al. strongly suggest that selective inhibition of m6A‐RNA methylation could offer an alternative means for targeting SLC7A11 overexpression for improving the treatments of HB or other cancers. This evidence concerns the gene SLC7A11 and hemoglobin measurement.